|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Matria Healthcare, Inc.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Three Months Ended December 31, |
Twelve Months Ended December 31, |
|||
| 2005 | 2004 | 2005 | 2004 | |
Reconciliation of Revenues As Reported to Revenues Before Reclassification |
||||
Revenues as reported |
$ 48,580 |
$ 38,462 |
$ 179,231 |
$ 145,087 |
Add revenues of Facet Technologies and German operations |
37,349 |
40,749 |
152,284 |
149,295 |
Revenues before Reclassification |
$ 85,929 |
$ 79,211 |
$ 331,515 |
$ 294,382 |
Reconciliation of Earnings (Loss) from Continuing Operations As Reported to Earnings from Continuing Operations Excluding One-Time Items Before Reclassification |
||||
Earnings from continuing operations as reported |
$ 1,510 |
$ (534) |
$ 4,014 |
$ (20,077) |
Add loss on retirement of Senior Notes, net of tax |
- |
- |
- |
14,144 |
Add additional interest due to timing of retirement |
- |
- |
- |
371 |
Add restructuring charges, net of tax |
- |
- |
- |
165 |
Earnings from continuing operations as adjusted |
1,510 |
(534) |
4,014 |
(5,397) |
Add earnings from Facet Technologies and German |
4,495 |
4,689 |
17,739 |
16,863 |
Earnings from continuing operations excluding |
$ 6,005 |
$ 4,155 |
$ 21,753 |
$ 11,466 |
Reconciliation of Diluted Earnings (Loss) Per Common Share from Continuing Operations As Reported to Diluted Earnings (Loss) Per Common Share from Continuing Operations Excluding One-Time Items Before Reclassification |
||||
Diluted earnings (loss) per common share as reported |
$ 0.07 |
$ (0.03) |
$ 0.20 |
$ (1.29) |
Add one-time items |
- |
- |
- |
0.94 |
Diluted earnings (loss) per common share excluding |
0.07 |
(0.03) |
0.20 |
(0.35) |
Add earnings from Facet Technologies and German |
0.21 |
0.26 |
0.86 |
1.05 |
Diluted earnings (loss) per common share excluding |
$ 0.28 |
$ 0.23 |
$ 1.06 |
$ 0.70 |
Shares Used in Calculating Net Earnings Per Share As Adjusted Before Reclassification |
||||
Weighted average shares outstanding, basic |
20,752 |
15,741 |
8,795 |
15,520 |
Shares issuable from assumed exercise of options |
1,017 |
- |
1,079 |
- |
Weighted average shares outstanding, diluted as adjusted |
21,769 |
15,741 |
19,874 |
15,520 |
Additional shares issuable from assumed exerciseof options and conversion of convertible notes |
- |
5,315 |
1,755 |
2,943 |
Weighted average shares outstanding, diluted as adjusted before Reclassification |
21,769 |
21,056 |
21,629 |
18,463 |
Note: For diluted earnings per share for the three-month and twelve-month periods ended December 31, 2004, interest on the convertible notes of $710 and $1,385, respectively, has been added to earnings from continuing operations as adjusted before Reclassification.